Alexander N. Narovlyansky

Prof. Dr. Alexander N. Narovlyansky


Research Focus & Metrics

Academic Career Length

46Years (1981-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 September 1996 in European Journal of Biochemistry
Verified
Journal Article
Open access
PDF file
KTKyril T. Turpaev
Kyril T. Turpaev
VZVladimir M. Zakhariev
Vladimir M. Zakhariev
ISIrina V. Sokolova
Irina V. Sokolova
ANAlexander N. Narovlyansky
Alexander N. Narovlyansky
AAAleftina M. Amchenkova
Aleftina M. Amchenkova
LFLyudmila Yu. Frolova
Lyudmila Yu. Frolova
We have analysed the structure of mRNA isoforms of the human gene encoding tryptophanyl-tRNA synthetase (Trp-tRNA synthetase) expressed in the epithelial CaOv cells and MT-4 lymphocytes. The Trp-tRNA synthetase gene is induced by interferon-γ in both lines and, in MT-4 lymphocytes, also by interferon-α. Four Trp-tRNA synthetase mRNA isoforms have different combinations of the first exons IA, IB and II. Two transcription initiation sites (P1 and P2) were detected 90 bp from each other. Processing of the primary transcript initiated from the PI start site generates the mRNA isoform where exon IA joins to exon II. The other three isoforms are produced by alternative splicing of the primary transcript produced from the P2 start site. Isoform 2 has a 3′-end fragment of exon IA joined to exon II. Isoform 3 contains exons IA and IB. Isoform 4 contains exon IA and exon III and lacks exon II encoding the N-terminus of the Trp-tRNA synthetase. Therefore, the two primary transcripts of the Trp-tRNA synthetase gene differ only in the 5′ flank sequence between P1 and P2, and this fragment regulates their processing. Both interferon-α and interferon-γ induce exon IA-containing and exon IB-containing isoforms of the Trp-tRNA synthetase mRNA.

26 February 1996 in FEBS Letters
Verified
Journal Article
Closed access
AVA. Vartanian
A. Vartanian
ANAlexander N. Narovlyansky
Alexander N. Narovlyansky
AAA. Amchenkova
A. Amchenkova
KTK. Turpaev
K. Turpaev
LKL. Kisselev
L. Kisselev

2 May 2022 in Polymers
Verified
Journal Article
Open access
PDF file
Alexander GerasimenkoAlexander Gerasimenko
Alexander Gerasimenko
EKEvgeny P. Kitsyuk
Evgeny P. Kitsyuk
UKUliana E. Kurilova Kurilova
Uliana E. Kurilova Kurilova
ISIrina A. Suetina
Irina A. Suetina
LRLeonid Russu
Leonid Russu
Olga E. GlukhovaOlga E. Glukhova
Olga E. Glukhova
Successful formation of electronic interfaces between living cells and electronic components requires both good cell viability and performance level. This paper presents a technology for the formation of nanostructured arrays of multi-walled carbon nanotubes (MWCNT) in biopolymer (albumin) layer for higher biocompatibility. The layer of liquid albumin dispersion was sprayed on synthesized MWCNT arrays by deposition system. These nanostructures were engineered using the nanosecond pulsed laser radiation mapping in the near-IR spectral range (λ = 1064 nm). It was determined that the energy density of 0.015 J/cm2 provided a sufficient structuring of MWCNT. The structuring effect occurred during the formation of C–C bonds simultaneously with the formation of a cellular structure of nanotubes in the albumin matrix. It led to a decrease in the nanotube defectiveness, which was observed during the Raman spectroscopy. In addition, laser structuring led to a more than twofold increase in the electrical conductivity of MWCNT arrays with albumin (215.8 ± 10 S/m). Successful electric stimulation of cells on the interfaces with the system based on a culture plate was performed, resulting in the enhanced cell proliferation. Overall, the MWCNT laser-structured arrays with biopolymers might be a promising material for extended biomedical applications.

2 February 2020 in Vaccines
Verified
Journal Article
Open access
PDF file
OMOlga Masalova
Olga Masalova
ELEkaterina Lesnova
Ekaterina Lesnova
RKRegina Klimova
Regina Klimova
EMEkaterina D. Momotyuk
Ekaterina D. Momotyuk
VKVyacheslav V. Kozlov
Vyacheslav V. Kozlov
AKAlla Kushch
Alla Kushch
Hepatitis C virus (HCV) is one of the major causes of chronic liver disease and leads to cirrhosis and hepatocarcinoma. Despite extensive research, there is still no vaccine against HCV. In order to induce an immune response in DBA/2J mice against HCV, we obtained modified mouse mesenchymal stem cells (mMSCs) simultaneously expressing five nonstructural HCV proteins (NS3-NS5B). The innate immune response to mMSCs was higher than to DNA immunization, with plasmid encoding the same proteins, and to naïve unmodified MSCs. mMSCs triggered strong phagocytic activity, enhanced lymphocyte proliferation, and production of type I and II interferons. The adaptive immune response to mMSCs was also more pronounced than in the case of DNA immunization, as exemplified by a fourfold stronger stimulation of lymphocyte proliferation in response to HCV, a 2.6-fold higher rate of biosynthesis, and a 30-fold higher rate of secretion of IFN-γ, as well as by a 40-fold stronger production of IgG2a antibodies to viral proteins. The immunostimulatory effect of mMSCs was associated with pronounced IL-6 secretion and reduction in the population of myeloid derived suppressor cells (MDSCs). Thus, this is the first example that suggests the feasibility of using mMSCs for the development of an effective anti-HCV vaccine.

20 February 2018 in Problems of Virology
Verified
Journal Article
Open access
PDF file
FEF. I. Ershov
F. I. Ershov
ANAlexander N. Narovlyansky
Alexander N. Narovlyansky
The review contains a brief analysis of the 60-year history of the discovery, study and medical application of interferons, a new group of remarkable proteins that have found wide medical application in the therapy of virological, oncological, neurological, ophthalmic and other pathologies. Modern data on the classification of interferons and the mechanisms of their action are given. Particular attention is paid to the clinical use of medications of interferon and its inducers.

31 October 2024 in Viruses
Verified
Journal Article
Open access
PDF file
ANAlexander N. Narovlyansky
Alexander N. Narovlyansky
APAlexander Vasilyevich Pronin
Alexander Vasilyevich Pronin
VPVladislav Poloskov
Vladislav Poloskov
ASAlexander Sanin
Alexander Sanin
MMMarina Vladimirovna Mezentseva
Marina Vladimirovna Mezentseva
EBEgor Bogdanov
Egor Bogdanov
Ongoing outbreaks and often rapid spread of infections caused by coronaviruses, influenza, Nipah, Dengue, Marburg, monkeypox, and other viruses are a concern for health authorities in most countries. Therefore, the search for and study of new antiviral compounds are in great demand today. Since almost all viruses with pandemic potential have immunotoxic properties of various origins, particular attention is paid to the search and development of immunomodulatory drugs. We have synthesised a new compound related to indole-3-carboxylic acid derivatives (hereinafter referred to as the XXV) that has antiviral and interferon-inducing activity. The purpose of this work is to study the effect of the XXV on the stimulation of the expression of toll-like receptor genes, interferons, and immunoregulatory cytokines in a macrophage-like cell model. In this study, real-time PCR methods were used to obtain data on the transcriptional activity of genes in macrophage-like cells. Stimulation of the genes of toll-like receptors TLR2, TLR3, TLR4, TLR7, TLR8, and TLR9 was detected. A high-fold increase in stimulation (from 6.5 to 16,000) of the expression of the TLR3 and TLR4 genes was detected after 4 h of exposure to the XXV. Increased activity of interferon (IFNA1, IFNA2, IFNB1, IFNK, and IFNλ1) genes with simultaneous stimulation of the expression of interferon receptor (IFNAR1 and IFNAR2) genes and signalling molecule (JAK1 and ISG15) genes was detected. Increased fold stimulation of the expression of the cytokine genes IL6, TNFA, IL12A, and IL12B was also observed. Thus, it is shown that the XXV is an activator of TLR genes of innate immunity, which trigger signalling mechanisms of pathogen “recognition” and lead to stimulation of the expression of genes of proinflammatory cytokines and interferons.